DE3680828D1 - Cinnolinderivate. - Google Patents

Cinnolinderivate.

Info

Publication number
DE3680828D1
DE3680828D1 DE8686303963T DE3680828T DE3680828D1 DE 3680828 D1 DE3680828 D1 DE 3680828D1 DE 8686303963 T DE8686303963 T DE 8686303963T DE 3680828 T DE3680828 T DE 3680828T DE 3680828 D1 DE3680828 D1 DE 3680828D1
Authority
DE
Germany
Prior art keywords
cinnoline derivatives
cinnoline
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686303963T
Other languages
English (en)
Inventor
James Franklin Resch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeneca Inc
Original Assignee
ICI Americas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ICI Americas Inc filed Critical ICI Americas Inc
Application granted granted Critical
Publication of DE3680828D1 publication Critical patent/DE3680828D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/28Cinnolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE8686303963T 1985-05-30 1986-05-23 Cinnolinderivate. Expired - Lifetime DE3680828D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858513639A GB8513639D0 (en) 1985-05-30 1985-05-30 Cinnoline compounds

Publications (1)

Publication Number Publication Date
DE3680828D1 true DE3680828D1 (de) 1991-09-19

Family

ID=10579908

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686303963T Expired - Lifetime DE3680828D1 (de) 1985-05-30 1986-05-23 Cinnolinderivate.

Country Status (25)

Country Link
US (1) US4886800A (de)
EP (1) EP0205272B1 (de)
JP (1) JPH0713062B2 (de)
KR (1) KR900004402B1 (de)
CN (1) CN1014060B (de)
AR (1) AR242026A1 (de)
AT (1) ATE66215T1 (de)
AU (1) AU592086B2 (de)
CA (1) CA1309406C (de)
DE (1) DE3680828D1 (de)
DK (1) DK162221C (de)
ES (3) ES8801803A1 (de)
FI (1) FI85584C (de)
GB (2) GB8513639D0 (de)
GR (1) GR861411B (de)
HU (1) HU199433B (de)
IE (1) IE58782B1 (de)
IL (1) IL78992A0 (de)
MW (1) MW4386A1 (de)
NO (1) NO171592C (de)
PH (1) PH23518A (de)
PL (1) PL149227B1 (de)
PT (1) PT82678B (de)
SU (1) SU1500158A3 (de)
ZA (1) ZA863664B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8702288D0 (en) * 1987-02-02 1987-03-11 Erba Farmitalia Cinnoline-carboxamides
DE68902490T2 (de) * 1988-02-09 1992-12-24 Ici America Inc Pharmazeutische zusammensetzung.
US4925844A (en) * 1988-02-09 1990-05-15 Ici Americas Inc. Antagonizing the pharmacological effects of a benzodiazepine receptor agonist
EP0743855A1 (de) * 1994-01-03 1996-11-27 Acea Pharmaceuticals, Inc. 8-Aza,6-Aza und 6,8-Diaza - 1,4 dihydrochinoxalin -2,3-dione und deren Verwendung als Glycin/NMDARezeptor Antagonisten
US6413958B2 (en) 2000-03-21 2002-07-02 Pharmacia & Upjohn Company 4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents
MXPA02009249A (es) 2000-03-21 2003-03-12 Upjohn Co 4-oxo-1,4-dihidro(1,8)naftiridin-3-carboxamidas como agentes antivirales.
NZ521524A (en) 2000-03-21 2004-04-30 Upjohn Co 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
CN1398258A (zh) 2000-03-21 2003-02-19 法玛西雅厄普约翰美国公司 用作抗病毒剂的4-羟基噌啉-3-甲酰胺化合物
RU2008122405A (ru) * 2005-12-20 2010-01-27 Астразенека Аб (Se) Замещенные производные циннолина в качестве модуляторов гамма-рецепторов и способ их синтеза
US7465795B2 (en) 2005-12-20 2008-12-16 Astrazeneca Ab Compounds and uses thereof
AR067028A1 (es) * 2007-06-19 2009-09-30 Astrazeneca Ab Compuestos y usos de los mismos 849
WO2010123441A1 (en) * 2009-04-21 2010-10-28 Astrazeneca Ab Crystalline form of 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n-propylcinnoline-3- carboxamide hydrogen sulphate, for treatment of anxiety disorders
WO2010123443A1 (en) * 2009-04-21 2010-10-28 Astrazeneca Ab Pharmaceutical composition comprising 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n- propylcinnoline-3-carboxamide hydrogen sulphate.
WO2010123440A1 (en) * 2009-04-21 2010-10-28 Astrazeneca Ab Pharmaceutical composition comprising 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n- propylcinnoline-3-carboxamide hydrogen sulphate and rate-controlling polymer
EP2726465A1 (de) * 2011-05-23 2014-05-07 Elan Pharmaceuticals Inc. Inhibitoren der lrrk2-kinaseaktivität
CN111905828B (zh) * 2020-08-24 2022-04-19 万华化学集团股份有限公司 一种萘基配体mof活性炭复合催化剂及其制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657241A (en) * 1970-03-12 1972-04-18 Dow Chemical Co Substituted cinnoline compounds
GB1306839A (en) * 1970-10-16 1973-02-14 Ici Ltd Pharmaceutical compositions
GB1474399A (en) * 1974-08-19 1977-05-25 Ici Ltd Cinnolin-3-yl carboxylic acids and derivatives thereof
US4085103A (en) * 1974-11-07 1978-04-18 Imperial Chemical Industries Limited 6-Substituted-4-hydroxycinnolin-3-yl-carboxylic acids and esters thereof
GB1472766A (en) * 1974-11-07 1977-05-04 Ici Ltd Hydroxycinnoline derivatives processes for their preparation and their use in pharmaceutical compositions
DD123525A1 (de) * 1976-02-10 1977-01-05
US4379929A (en) * 1981-03-19 1983-04-12 Eli Lilly And Company 4(1H)-Oxocinnoline-3-carboxylic acid derivatives
US4729782A (en) * 1983-09-14 1988-03-08 Lafarge Coppee Pollen suppressant comprising a fused pyridazinone
GB8702288D0 (en) * 1987-02-02 1987-03-11 Erba Farmitalia Cinnoline-carboxamides

Also Published As

Publication number Publication date
DK162221C (da) 1992-03-02
GR861411B (en) 1986-08-28
GB8513639D0 (en) 1985-07-03
ATE66215T1 (de) 1991-08-15
HUT41012A (en) 1987-03-30
PL149227B1 (en) 1990-01-31
FI862315A (fi) 1986-12-01
AR242026A1 (es) 1993-02-26
EP0205272B1 (de) 1991-08-14
JPS61280483A (ja) 1986-12-11
IE861267L (en) 1986-11-30
DK256386D0 (da) 1986-05-30
IL78992A0 (en) 1986-09-30
NO862141L (no) 1986-12-01
IE58782B1 (en) 1993-11-17
ES8801903A1 (es) 1988-03-01
ES557790A0 (es) 1988-10-01
ES555546A0 (es) 1988-02-16
ZA863664B (en) 1987-03-25
AU5781986A (en) 1986-12-04
PH23518A (en) 1989-08-16
EP0205272A2 (de) 1986-12-17
ES557522A0 (es) 1988-03-01
KR900004402B1 (ko) 1990-06-25
MW4386A1 (en) 1987-06-19
FI85584C (fi) 1992-05-11
NO171592C (no) 1993-04-07
FI85584B (fi) 1992-01-31
CA1309406C (en) 1992-10-27
US4886800A (en) 1989-12-12
DK162221B (da) 1991-09-30
AU592086B2 (en) 1990-01-04
CN86104358A (zh) 1987-04-01
NO171592B (no) 1992-12-28
KR860008986A (ko) 1986-12-19
ES8801803A1 (es) 1988-02-16
PT82678A (en) 1986-06-01
JPH0713062B2 (ja) 1995-02-15
CN1014060B (zh) 1991-09-25
ES8802611A1 (es) 1988-10-01
FI862315A0 (fi) 1986-05-30
GB8611419D0 (en) 1986-06-18
SU1500158A3 (ru) 1989-08-07
HU199433B (en) 1990-02-28
DK256386A (da) 1986-12-01
EP0205272A3 (en) 1987-11-19
PT82678B (pt) 1988-03-03

Similar Documents

Publication Publication Date Title
ATE77088T1 (de) 8-phenylxanthine.
DE3685611T2 (de) Polysiloxanelastomer.
FI870621A (fi) Bradykininantagonistspeptider.
ATE55980T1 (de) 2-hydroxy-3-phenoxypropylamine.
DE3668776D1 (de) Endotubus.
DE3685936T2 (de) Photodensitometer.
DE3687028T2 (de) Perfluoroaminoaether.
DE3668381D1 (de) Contactlinse.
DE3687867D1 (de) Mikrorechner.
DE3668885D1 (de) Fluorbenzylester.
DE3686168T2 (de) Hydroxyphenylthioalkylketoalkohole.
FI863692A0 (fi) Antipsykotiska -karboliner.
DE3680828D1 (de) Cinnolinderivate.
DE3669772D1 (de) Russblaeser.
FI872008A0 (fi) Delbar flasklaoda.
DE3688642D1 (de) Fdm-tdm-transmultiplexer.
DE3686729D1 (de) Aminoalkylpyridinamide.
DE3670979D1 (de) Raederfalzapparat.
DE3673746D1 (de) Pudermine.
DE3670767D1 (de) Rioprostil-pvp-komplex.
DE3667938D1 (de) Raederfalzapparat.
FI852741L (fi) Anordning foer behandling av vatten.
ATE59382T1 (de) Cyclohexanalkansaeuren.
ATE48748T1 (de) Streubuechse.
ATE51129T1 (de) Epiliergeraet.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition